 |
|
Imperial to lead the way in developing vaccines against bio-weapons
November 01, 2004Scientists at Imperial College London and Hammersmith Hospital are to help develop new vaccines in case of a terrorist release of biological agents such as anthrax.
The team has been awarded $4.5 million by the National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institute of Health (NIH) to develop new vaccines against a possible bio-terrorist attack, and new emerging infectious diseases.
Dr Danny Altmann, lead researcher at Imperial College London and Hammersmith Hospital comments: "Despite many of the current possible bio-weapons having existed for many years we only have a limited defence against them. With the increased threat of terrorism and bio-terrorism it is vital that we develop a much greater understanding of these biological agents including anthrax. This programme will allow us to develop more effective measures to protect the population in the event of an attack.
"At the same time, the research will also be of huge benefit in understanding new and emerging infectious diseases, whilst we carry out fundamental research into immunology. This fundamental research will also help to develop much more effective diagnostics and treatment which can be used for a variety of diseases."
Working with colleagues from the University of Newcastle, Defence Science and Technology Laboratory, Porton Down, UK, University of Maryland and the US Navy, Dr Altmann will use state of the art technologies to develop new diagnostics and treatments for anthrax.
Imperial College, University of London
"At the same time, the research will also be of huge benefit in understanding new and emerging infectious diseases, whilst we carry out fundamental research into immunology. This fundamental research will also help to develop much more effective diagnostics and treatment which can be used for a variety of diseases."
Working with colleagues from the University of Newcastle, Defence Science and Technology Laboratory, Porton Down, UK, University of Maryland and the US Navy, Dr Altmann will use state of the art technologies to develop new diagnostics and treatments for anthrax.
Imperial College, University of London
Anthrax Current Events and Anthrax News RSSMilestone biodefense publication by Elsevier journal Vaccine
Last week during the 'Vaccines for Biothreats and Emerging and Neglected Diseases Symposium' in Galveston TX, USA, the Elsevier journal Vaccine released a supplement dedicated to vaccines for biodefense.
Cigarettes Harbor Many Bacteria Harmful to Human Health
Cigarettes are "widely contaminated" with bacteria, including some known to cause disease in people, concludes a new international study conducted by a University of Maryland environmental health researcher and microbial ecologists at the Ecole Centrale de Lyon in France.
New explanation for nature's hardiest life form
Got food poisoning? The cause might be bacterial spores, en extremely hardy survival form of bacteria, a nightmare for health care and the food industry and an enigma for scientists.
Better immune defense against anthrax
Scientists discover a gene in anthrax-causing bacteria may help defend against this form of bio-warfare.
Argonne researchers develop method that aims to stabilize antibodies
Researchers at the U.S. Department of Energy's Argonne National Laboratory have developed a systematic method to improve the stability of antibodies.
Early detection and quick response are key to defense against anthrax attack
A large attack on a major metropolitan area with airborne anthrax could affect more than a million people, necessitating their treatment with powerful antibiotics.
Data published in the New England Journal of Medicine support use of raxibacumab (ABthrax) for the treatment of inhalation anthrax
Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced publication by the New England Journal of Medicine of the results of two pivotal animal efficacy studies, which showed the life-saving potential of the Company's human monoclonal antibody drug raxibacumab.
One secret to how TB sticks with you
Mycobacterium tuberculosis is arguably the world's most successful infectious agent because it knows how to avoid elimination by slowing its own growth to a crawl.
Unexpected discovery can open a new chapter in the fight against tuberculosis
A close relative of the microorganism that causes tuberculosis in humans has been found to form spores.
Genetic switch potential key to new class of antibiotics
Researchers have determined the structure of a key genetic mechanism at work in bacteria, including some that are deadly to humans, in an important step toward the design of a new class of antibiotics.
More Anthrax Current Events and Anthrax News Articles
 |
Among the Living by Anthrax Pioneering metal band Anthrax, one of the genre's most influential, innovative and respected groups, melded the speed and fury of hardcore punk with the guitars and vocals of heavy metal to help create speed and thrash metal. Now what many consider the group's greatest album, 1987's "Among The Living," has been expanded with bonus tracks and a concert DVD, and digitally remastered for the first time, for the CD+DVD package AMONG THE LIVING (DELUXE EDITION) "Among The Living," originally produced by Eddie Kramer and Anthrax, was the band's third full-length album and featured the lineup of singer Joe Belladonna, lead guitarist Dan Spitz, rhythm guitarist Scott Ian, bassist Frank Bello and drummer Charlie Benante. Building on an underground following with signature tracks such as "I... |
 |
Among the Living by Anthrax If Metallica and Slayer invented speed metal, Anthrax brought it to the East Coast and imbued it with the attitude and excitement of New York hardcore. Among the Living is, without a doubt, their finest hour--a roaring, adrenaline-pumped collection of flailing beats, precise, razor-edged riffs and shout-along refrains. Unlike most full-throttle metal vocalists of the era, Joey Belladonna chose to sing as well as shout, giving songs like "Among the Living," "Indians" and "Efilnikcufecin" ("nice fuckin' life" spelled backwards) a decided melodic edge. Yet Scott Ian and Dan Spitz's buzzsaw guitar flurries, and Charlie Benante's insistent drumming, prevented the songs from ever degenerating into the run-of-the-mill heavy metal they so despised. --Jon Wiederhorn |
 |
Caught in a Mosh: BBC Live in Concert by Anthrax CAUGHT IN A MOSH: BBC LIVE IN CONCERT is the official U.S. debut release of the double CD set, which brings together two live performances from the 1987 UK "Among The Living" tour: their sold out Hammersmith Odeon show and their storming performance at the Donnington Festival. |
 |
Spreading the Disease by Anthrax |
![Among The Living [Explicit]](http://ecx.images-amazon.com/images/I/51ZprdREUQL._SL160_.jpg) |
Among The Living [Explicit] Anthrax (Primary Contributor) |
 |
Persistence of Time by Anthrax |
 |
We've Come for You All by Anthrax You'll find no rap metal or nu metal on We've Come for You All--just Anthrax's inimitable thrash-metal melded with contemporary melodies, dynamics, and booming, arena-worthy production. Two way-cool guests--Roger Daltrey and Pantera guitarist Dimebag Darrell--are under-utilized on their respective songs, but with machine-gun, heart-pounding double-bass drums and vocalist John Bush's convincing snarl, it hardly matters. Bush, who has been in Anthrax since the early '90s, has been part of much of the group's best and most mature (if not most commercially successful) material. The dynamic "Superhero" is a winner, as is the radio-ready, not-too-heavy "Safe Home." "Nobody Knows Anything" and "Strap It On" are the best of the heaviest entries. Effective acoustic moments, Scott Ian's guitar... |
 |
State of Euphoria by Anthrax |
 |
Attack of the Killer B's by Anthrax |
|
Bring The Noise Anthrax (Primary Contributor) |
| © 2009 BrightSurf.com |